Unknown

Dataset Information

0

Genotype-Associated Differential NKG2D Expression on CD56+CD3+ Lymphocytes Predicts Response to Pegylated-Interferon/Ribavirin Therapy in Chronic Hepatitis C.


ABSTRACT: Hepatitis C virus (HCV) genotype 1 infections are significantly more difficult to eradicate with PEG-IFN/ribavirin therapy, compared to HCV genotype 2. The aim of this work is to investigate the difference of immunological impairments underlying this phenomenon. Pre-treatment NKG2D expression on peripheral CD56+CD3+ lymphocytes and CD56+CD3- NK cells from cases of chronic hepatitis C were analyzed and assessed by treatment effect. Two strains of HCV were used to co-incubate with immune cells in vitro. NKG2D expression on peripheral CD56+CD3+ lymphocytes, but not NK cells, was significantly impaired in genotype 1 infection, compared to genotype 2. When peripheral blood mononuclear cells from healthy donors were co-incubated with TNS2J1, a genotype 1b/2a chimera strain, or with JFH1, a genotype 2a strain, genotype-specific decrease of NKG2D on CD56+CD3+ lymphocytes, but not NK cells, was observed.?Pre-treatment NKG2D expression on peripheral CD56+CD3+ lymphocytes significantly correlated with reduction in serum HCV RNA levels from week 0 to week 4, and predicted treatment response. Ex vivo stimulation of peripheral CD56+CD3+ lymphocytes showed NKG2D expression-correlated IFN-? production. In conclusion, Decreased NKG2D expression on CD56+CD3+ lymphocytes in chronic HCV genotype 1 infection predicts inferior treatment response to PEG-IFN/ribavirin therapy compared to genotype 2.

SUBMITTER: Chu PS 

PROVIDER: S-EPMC4428701 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Genotype-Associated Differential NKG2D Expression on CD56+CD3+ Lymphocytes Predicts Response to Pegylated-Interferon/Ribavirin Therapy in Chronic Hepatitis C.

Chu Po-sung PS   Ebinuma Hirotoshi H   Nakamoto Nobuhiro N   Sugiyama Kazuo K   Usui Shingo S   Wakayama Yuko Y   Taniki Nobuhito N   Yamaguchi Akihiro A   Shiba Shunsuke S   Yamagishi Yoshiyuki Y   Wakita Takaji T   Hibi Toshifumi T   Saito Hidetsugu H   Kanai Takanori T  

PloS one 20150512 5


Hepatitis C virus (HCV) genotype 1 infections are significantly more difficult to eradicate with PEG-IFN/ribavirin therapy, compared to HCV genotype 2. The aim of this work is to investigate the difference of immunological impairments underlying this phenomenon. Pre-treatment NKG2D expression on peripheral CD56+CD3+ lymphocytes and CD56+CD3- NK cells from cases of chronic hepatitis C were analyzed and assessed by treatment effect. Two strains of HCV were used to co-incubate with immune cells in  ...[more]

Similar Datasets

| S-EPMC4865958 | biostudies-literature
| S-EPMC4385537 | biostudies-literature
| S-EPMC3502985 | biostudies-literature
| S-EPMC3513206 | biostudies-other
| S-EPMC5554392 | biostudies-literature
| S-EPMC4070902 | biostudies-literature
| S-EPMC5122234 | biostudies-literature
| S-EPMC4650907 | biostudies-other
| S-EPMC3439299 | biostudies-literature
| S-EPMC5491091 | biostudies-literature